Market Place
Sourcing Support
Genentech tries again on diversity aim for Alzheimer`s program
08 Aug 2022 //
FIERCEBIOTECH
Genentech, AC Immune reveal more about crenezumab failure
02 Aug 2022 //
FIERCEBIOTECH
NextGen: Alzheimer`s therapy developers find reason for optimism
29 Jun 2022 //
FIERCEBIOTECH
Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial
17 Jun 2022 //
PHARMAPHORUM
AC Immune Provides Update On Alzheimer’s Prevention Initiative Study Evaluating Crenezumab
16 Jun 2022 //
PRESS RELEASE
Shehnaaz Suliman dives back into Alzheimer`s at Alector
14 Dec 2019 //
ENDPTS
Investors lost big as Alzheimer’s R&D went over the cliff in 2019
11 Sep 2019 //
ENDPOINTS NEWS
Pharma companies clear the R&D decks in Q4
11 Feb 2019 //
PHARMAPHORUM
Is Biogen’s Aducanumab for Alzheimer’s the Holy Grail or Cold Fusion?
03 Feb 2019 //
BIOSPACE
Roche, AC Immune drop Alzheimer drug trials after setback
31 Jan 2019 //
REUTERS
Roche halts phase 3 anti-Abeta Alzheimer’s test as flops rack up
30 Jan 2019 //
FIERCE BIOTECH
Roche to discontinue Phase III clinical studies of crenezumab in early Alz` Dis
30 Jan 2019 //
PRESS RELEASE
Roche drops Alzheimer drug trials after setback
30 Jan 2019 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.